Furthermore, patients with a T2-hypointense tumor experienced a higher % IGF-1 reduction compared to the subjects with a non-hypointense lesion [65.8% (IQR 51.5-81.4) vs. 35.5% (IQR 23.4-62.9); p=0.021] (Figure 3B). Here, IGF1 is linked to neoplasm.